March 28, 2018
Sumitomo Dainippon Pharma and Kobe-based biotech Carna Biosciences said on March 27 that they have struck a four year collaborative research pact aimed at discovering novel kinase inhibitors and their subsequent development and commercialization for psychiatric and neurological disorders. Through...read more